Actualités produits
GEA introduces pharma separator lines aseptic and pure for biopharmaceutical separation processes
22 Aug 2022
With a view to the very different hygiene requirements in individual pharmaceutical processes, GEA engineers developed a new, fully comprehensive portfolio of plug & produce pharmaceutical separators. GEA presents the separator lines aseptic and pure at ACHEMA 2022 in Frankfurt. The aseptic and pure separator lines are used in all pharmaceutical and biotechnological downstream processes and meet customer-specific as well as process-required demands. GEA sees the uncompromising hygienic design reliability and the possibility of maximum yield in the respective processes as the decisive plus points of aseptic and pure.
The pharmaceutical separator lines "aseptic" and "pure" are developed to the highest GEA standards at the German GEA Westfalia Separator plant in Oelde, where they are built and tested. All features for pharmaceutical cleanliness requirements such as an automatic CIP (Cleaning-in-Place), SIP (-Sterilization-in-Place), easy validation and a high-end qualification package are included. In addition, the pharmaceutical separators support GEA customers in their quality standard reviews with the help of the cGMP validation process ("Current Good Manufacturing Practice, cGMP).
GEA separator line aseptic
The aseptic line includes SIP processing and stands for the highest hygienic pharmaceutical requirements. It offers customers with highly hygienic processes gentle processing of, for example, human and veterinary vaccines, monoclonal antibodies (mAb), e-coli, insulin, starter cultures and probiotic products.
GEA's separator line aseptic including SIP offers customers with highly hygienic processes gentle processing of, for example, human and veterinary vaccines, monoclonal antibodies (mAb), e-coli, insulin, starter cultures and probiotic products. (Photo: GEA)
GEA separator line pure
The pure line gives highest variability and is perfectly tailored to the diverse process requirements of the biopharma industry. It is recommended for customers with applications with varying hygienic requirements, such as for food supplements, therapeutic proteins, pharmaceutical extractions, and in the recovery of extracellular and intracellular enzymes. Here, the separator line pure offers the highest variability in the selection of required hygienic components.
GEA presents the separator pure line at ACHEMA 2022. (Photo: GEA)
flexChange 3-in-1 bowl concept from GEA for producers with frequent product changes
The GEA flexChange 3-in-1 bowl concept of the new separator series aseptic and pure ensures high flexibility, which means a plus in competitiveness especially for Contract Manufacturing Organizations (CMO) and operators of pilot plants. The principle: the customer selects the bowl variant ideally suited to his products with solid content from 5 vol% to 35 vol% or higher, depending on product. This results in maximum yield with every product change. One GEA Pharma Skid with flexChange concept thus replaces three plants.
Contact
Dr. Michael Golek
Media Relations
GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476
Düsseldorf
Germany
+49 211 9136-0
About GEA
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German MDAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.
